Kindred Biosciences (KIN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts KIN Hot Sheet
Join SI Premium – FREE
Kindred Biosciences (NASDAQ: KIN) reported Q2 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). R
For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
